# Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal

> **NCT04511988** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 20 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **OTHER:** Diagnostic Test

## Key facts

- **NCT ID:** NCT04511988
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-17
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04511988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04511988, "Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04511988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*